People with genetic risks for Alzheimer's disease may exhibit changes in brain structure and reduced performance in cognitive tests long before symptoms of the neurodegenerative disease become obvious.
Recent studies have linked air pollution to increased risks for Alzheimer's disease and other health problems. A new study reports a reduction of atmospheric fine particulates and better air quality can reduce the risk of Alzheimer's and other dementias.
A new, improved DBS technique that targets specific subpopulations of neurons in the globus pallidus with short bursts of stimulation shows promising results as a treatment for Parkinson's disease.
Axitinib, a chemotherapy drug that inhibits the growth of new blood vessels in the brain, improved memory and cognition in mouse models of Alzheimer's disease.
Scientists have identified three acidic cannabinoids in cannabis that reduces seizure activity in mouse models of Dravet syndrome.
Fenchol, a natural compound found in basil and other plans, appears to have a neuroprotective effect against Alzheimer's disease. Fenchol reduces the formation of zombie neural cells and increases the degradation of non-functional amyloid beta, allowing for quicker clearance of the protein from the brain.
Synthesizing a human embryo from stem cells and using gene editing to insert the Huntingtin gene, researchers found the mutation affected the size of germ layers compared to the control embryos. Findings suggest Huntington's disease may be a neurodevelopmental disorder that presents as a neurodegenerative disease later
A new study reveals an association between high blood pressure in a person's thirties and forties to smaller brain size and an increased risk of developing dementia later in life.
A four-week course of pain reprocessing therapy (PRT) provided up to 12 months of relief from pain for chronic pain sufferers. Additionally, the psychological treatment program altered brain networks associated with pain processing.
Study shows chronic hyperglycemia impairs working memory performance and alters fundamental aspects of working memory brain networks. The findings strengthen the link between type 2 diabetes and Alzheimer's disease.
A combination of approved and novel therapeutics improved survival rates and reduced both tumor volume and growth for those suffering from glioblastoma brain cancer.